Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 13, 2020

Total Value ($000): $96,131 (100.0% shares, 0.0% debt)

Holdings (17)

LGND LIGAND PHARMACEUTICALS 31.9%
Value ($000) $30,645 Shares 321,500 Est. Cost $64.91 Unrealized +5.1%
IVERIC BIO INC 13.9%
Value ($000) $13,323 Shares 2,362,240 Est. Cost $1.52 Unrealized
AMRYT PHARMA LTD - SPNR ADR 9.8%
Value ($000) $9,458 Shares 765,236 Est. Cost $12.36 Unrealized
CTI BIOPHARMA CORP 8.4%
Value ($000) $8,102 Shares 3,768,597 Est. Cost $2.16 Unrealized
CATALYST BIOSCIENCES INC 6.3%
Value ($000) $6,069 Shares 1,411,412 Est. Cost $4.61 Unrealized
DMAC DIAMEDICA THERAPEUTICS INC 5.1%
Value ($000) $4,861 Shares 1,146,470 Est. Cost $4.62 Unrealized +14.6%
STRONGBRIDGE BIOPHARMA PLC 4.2%
Value ($000) $4,042 Shares 1,924,956 Est. Cost $2.10 Unrealized
ANTARES PHARMA INC 3.4%
Value ($000) $3,255 Shares 1,205,501 Est. Cost $2.70 Unrealized
XOMA XOMA CORP 2.9%
Value ($000) $2,830 Shares 150,213 Est. Cost $14.24 Unrealized +31.6%
ADAMAS PHARMACEUTICALS INC 2.8%
Value ($000) $2,709 Shares 657,467 Est. Cost $4.81 Unrealized
APOLLO ENDOSURGERY INC 2.5%
Value ($000) $2,409 Shares 1,425,435 Est. Cost $4.35 Unrealized
NEOS THERAPEUTICS INC 2.4%
Value ($000) $2,325 Shares 4,384,199 Est. Cost $1.80 Unrealized
CPIX CUMBERLAND PHARMACEUTICALS 2.0%
Value ($000) $1,892 Shares 589,497 Est. Cost $5.80 Unrealized -43.3%
CHIASMA INC 1.6%
Value ($000) $1,505 Shares 350,000 Est. Cost $4.30 Unrealized
AFFIMED NV 1.3%
Value ($000) $1,212 Shares 357,666 Est. Cost $3.39 Unrealized
IDXG INTERPACE BIOSCIENCES INC 0.9%
Value ($000) $880 Shares 284,730 Est. Cost $3.09 Unrealized
PROGENITY INC 0.6%
Value ($000) $614 Shares 68,062 Est. Cost $9.00 Unrealized